ARCHIVES

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Copeland Named Director, UF Cancer Center

February 10, 1995

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004

Contracts Cutback Canceled 7 RFPs

August 8, 1980

NCI’s Plan to Limit Growth of Core Grants Prompts Smaller Cancer Centers to Cry Foul

May 11, 2012

Blochs to Sponsor “Fighting Cancer”

May 9, 1986